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We have developed an animal model of experimental HTLV-1 infection in Saimiri sciureus monkeys in order to study both the immunological
and the virological aspects of the infection. As cytokines expressed by immune cells play an essential role during viral infection, we have studied
the correlation between the expression of some Th1/Th2 cytokines, including IL-2, IL-5, IL-6, IL-10, and IFN-γ, and immunological dynamics
during primary and chronic HTLV-1 infection in this model. We first demonstrated that, during primary infection, IFN-γ, IL-2 and IL-10 are
expressed at different times and levels. The expression of these cytokines is concomitant with the increase in the numbers of CD4+, CD8+ and
CD16+ cells and with the presence of tax/rex viral mRNA. These data indicate the involvement of various cell types in the antiviral immune
response. Subsequently, we showed that peripheral blood mononuclear cells freshly isolated from chronically infected monkeys express IFN-γ and
IL-6 at higher levels than those from uninfected animals. IFN-γ expression is quantitatively correlated to the proviral load and to the presence of
circulating effector T-cells against Tax peptide, as detected by Elispot. Further studies will be needed to determine the effective role of these
cytokines and other immune system modulators in the control of viral replication during primary HTLV-1 infection or latency.
© 2006 Elsevier Inc. All rights reserved.Keywords: HTLV-1; Cytokine; Gene expression; RT-PCR; Proviral load; Cellular immunityIntroduction
Human T-cell lymphotropic virus type 1 (HTLV-1), the
causative agent of adult T-cell leukaemia/lymphoma (ATLL)
(Yoshida, 1983) and of tropical spastic paraparesis/HTLV-1-
associated myelopathy (TSP/HAM) (Gessain et al., 1985), has
also been associated with paediatric infectious dermatitis
(Lagrenade et al., 1990), uveitis (Mochizuki et al., 1992),⁎ Corresponding author. Present address: CIRMF, Département de Rétro-
virologie, B.P. 769 Franceville, Gabon. Fax: +241 67 72 95.
E-mail address: m.kazanji@cirmf.org (M. Kazanji).
1 Present address: Animal Models and Retroviral Vaccines Section, NCI,
Bethesda, MD 20892-5055, USA.
0042-6822/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2006.11.028arthropathy (Ijichi et al., 1990) and polymyositis (Morgan et al.,
1989). Owing to the inherent difficulty of obtaining human
specimens shortly after infection, a relevant animal model was
essential for better understanding of host–virus interactions, virus
transmission, the natural history of infection and the pathogenesis
of HTLV-1-associated diseases. Such models could also be
critical for testing candidate vaccines (Kazanji et al., 2001).
We have previously shown that the squirrel monkey, Saimiri
sciureus, a South American non-human primate that is free of
simian T-cell leukaemia virus, is susceptible to experimental
infection with syngeneic or allogeneic HTLV-1-immortalized
cells (Kazanji et al., 1997b). As in humans, such experimental
inoculation leads to chronic infection, and the HTLV-1 provirus
is still detectable by polymerase chain reaction (PCR) in the
403J.-M. Heraud et al. / Virology 361 (2007) 402–411peripheral blood mononuclear cells (PBMCs) of these animals
up to 7 years after inoculation.
We have also shown that PBMCs, spleen and lymph nodes
represent the major reservoirs for HTLV-1 during the early
phase of infection. In a previous study, in which we investigated
the virological changes during primary infection, we showed
that the HTLV-1 provirus could be detected by PCR as early as
6 days after infection. Competitive PCR showed that the
proviral load increased in the PBMCs of infected animals
shortly after infection and remained stable thereafter. RT-PCR
and in situ hybridization indicated, however, that HTLV-1 tax/
rex mRNA is transcribed only transiently during the early stage
of infection (Kazanji et al., 2000).
The humoral and cellular immune responses to HTLV-1 were
also evaluated at various times after HTLV-1 inoculation. Anti-
HTLV-1 antibodies were not detected 6 and 12 days after
injection; however, by 35 days, high antibody titres were
present. Anti-p40tax and anti-env cytotoxic activity were also
detected 2 months after infection and remained detectable
thereafter (Kazanji, 2000; Kazanji et al., 2000). This CTL
response in monkeys appears to be comparable to that observed
in asymptomatic human HTLV-1 carriers. In carriers and in
TSP/HAM patients, the CTL response is also directed mainly
against the p40 Tax protein (Jacobson, 2002). It has been
suggested that this cellular response plays a major role in
controlling HTLV-1 replication and then in maintaining a low
viral load (Bangham, 2000; Bangham, 2003; Bangham et al.,
1996; Jacobson, 2002). In simian immunodeficiency virus
infection, the prognosis of subsequent disease is likely to
depend on the rate of viral replication relative to the antiviral
immune response, especially during the first few days after
infection. Furthermore, different cytokine profiles might
influence the outcome. As there are no data on the dynamics
of the cellular immune response during primary HTLV-1
infection, we decided to use our non-human primate model of
HTLV-1 infection to study the evolution and role of this
response in HTLV-1 infection. We previously developed a
quantitative method based on competitive RT-PCR to evaluate
the expression of various Th1 and Th2 cytokines, including IL-
1β, IL-2, IL-5, IL-6, IL-10, TNF-α and IFN-γ, from squirrel
monkeys in vivo (fresh PMBCs) (Heraud et al., 2002). In the
present study, we evaluated the relation between the CD4+,
CD8+ and CD16+ cell response and the expression of some Th1
and Th2 cytokines, including IL-2, IL-5, IL-6, IL-10 and IFN-γ,
during primary infection and during latency in squirrel
monkeys. At a later stage of infection, the expression of these
cytokines was compared with the proviral load and with the
presence of circulating effector T-cells against Tax obtained
from chronically infected animals.
Results
A transitory concomitant increase in T-cell response during
primary infection
To investigate and identify the T-cell response, we first
generated a polyclonal serum directed against squirrel monkeyCD8+ T-cells (see Materials and methods and Fig. 1), as none of
the commercially available anti-CD8+ preparations cross-
reacted with the squirrel monkeys CD8+ cell subset.
Two monkeys were inoculated with HTLV-1-transformed
cells as previously described (Kazanji et al., 1997b), and
lymphocyte and leukocyte counts and the anti-HTLV-1 humoral
response were monitored for up to 3 months. As shown in Fig.
2, both animals showed a transient increase in lymphocytes and
leukocytes, with a peak on day 7 after infection. The cell
numbers decreased after 12 days and remained stable thereafter.
HTLV-1 ELISA revealed a positive antibody response against
the virus 30 days after inoculation (Fig. 2), which remained at a
high level thereafter. To confirm these observations, and to
evaluate whether the increase in the white blood cells and
lymphocytes count was or not due to an allogeneic response to
the injected cells, five additional animals were inoculated. Four
monkeys (A050C, A115C, 96070 and A029C) received the
HTLV-1-transformed cell line as described above and one
control monkey (A118C) was given the same number of Jurkat
cells. As seen in Fig. 3, all four HTLV-1-infected animals
showed increased absolute numbers of lymphocytes as well as
in WBC (data not shown). In particular, we observed increased
numbers of both CD4+ and CD8+ T cells between days 4 and
14, with a peak between days 7 and 9 (Fig. 3). Two of the four
animals (A050C and A115C) also showed a significant increase
in the number of CD16+ cells, with a peak at day 7. The cells of
the control animal showed no significant modification.
Expansion of T cells and natural killer (NK) cell subsets
during viral infection might be concomitant with the expression
of various cytokines involved in the immune response. To assess
this idea, wemeasured themRNA expression of IL-2, IL-5, IL-6,
IL-10 and IFN-γ, which are known to play an important role in
the humoral and cellular response during primary infection.
IFN-γ, IL-2 and IL-10 expression and detection of HTLV-1
tax/rex mRNA during primary HTLV-1 infection
IL-2, IL-5, IL-6, IL-10 and IFN-γ expression was evaluated
by RT-PCR up to 2 weeks after infection in the four infected
animals and in the control animal. The animals did not differ
significantly in the expression of IL-5 and IL-6 (data not
shown); however, IL-10 and IFN-γ expression was observed on
days 4–14 in the infected animals but not in the control (Fig. 4).
Transitory expression of IL-2 was observed from day 4 to day 7.
Infected monkeys showed peak expression of IL-10 on day 7,
which decreased significantly during the next few days.
To determine the relation between these observations and
HTLV-1 expression during the same period, the expression of
tax/rex mRNA was investigated by RT-PCR. Tax/rex mRNA
was detected only from day 7 to day 11 but was undetectable by
day 14 (Fig. 4).
Cytokine expression in chronically HTLV-1-infected monkeys
and association with HTLV-1 proviral load
To investigate the role of these cytokines at a later stage of
HTLV-1 infection, we also evaluated their expression in fresh
Fig. 1. Detection of Saimiri sciureus CD8 α-chain expression and flow cytometry analysis of CD8+ T cells labelled with anti-squirrel monkeys CD8 cells. (A) Lane 1,
mock-transfected 293T; lane 2, 293T cells transfected with plasmid pcDNA4/HisMax-Lac Z; lane 3, 293T cells transfected with recombinant pcDNA4/HisMax-CD8-
α plasmid. Antibody against β-tubulin was used as control for protein loading. (B1 and B2) Newly generated polyclonal directed against squirrel monkey (S. sciureus)
CD8 α-chain can detect cells expressing this cell marker. Cytometric analysis revealed that 49% of total PBMCs were CD8+ cells (B1), and 76% of CD2+ cells from
CD4+-depleted cells fraction were CD8+ cells (B2).
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monkeys. We found no difference in IL-2, IL-5 and IL-10 levels
as compared with uninfected monkeys (Fig. 5) and, higher IL-6
and IFN-γ expression was found in most HTLV-1-infectedFig. 2. Immunological response during primary HTLV-1 infection in squirrel monk
inoculation, and leukocytes and lymphocytes (WBC) were counted. During the sam
dotted line represents the cut-off value). OD, optical density.animals, as the expression of these two cytokines is very low or
undetectable in uninfected animals.
To determine which T-cell types express IFN-γ, CD4+ and
CD8+ cells were purified, and IFN-γ expression was evaluatedeys. Blood samples were collected on days 0, 1, 7, 14, 21, 30, 60 and 90 after
e period, the antibody response against HTLV-1 was measured by ELISA (the
Fig. 3. Absolute numbers of peripheral CD4+, CD8+and CD16+ cells during primary HTLV-1 infection in squirrel monkeys. Four animals (A115C, 96070, A050C and
A029C) were inoculated with an HTLV-1-transformed cell line (EVO/1540). On days 0, 4, 7, 9, 11, 14 and 30 after infection, lymphocytes and CD4+, CD8+ and
CD16+ cells were counted by cytometry. As a control, one animal (A118C) was inoculated with Jurkat cells.
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cells expressed IFN-γ. CD4+ T cells were the main IFN-γ-
expressing subset in two HTLV-1-infected animals (1491 and
94119), whereas CD8+ was the main subset in animal 1540.
There was no difference between CD4+ and CD8+ T-cell IFN-γ
expression in the fourth monkey (1715) (Table 1). We further
evaluated the relation between IFN-γ expression and HTLV-1
proviral load. Statistical analyses of the data presented in Table
1 using the Spearman's Rank Correlation Test demonstrated a
strong positive correlation between the expression of IFN-γ in
total PBMCs and the proviral load (Spearman rank correlation
coefficient, 0.97 with p=0.033). Nevertheless the same test
performed on CD4+ and CD8+ T-cells subset revealed only a
positive but non-significant relation between IFN-γ expression
and proviral load (rs=0.82, with p=0.13, for CD4
+ cells, and
rs=0.40, with p=0.10, for CD8
+ cells).
Frequency of circulating effector T-cells against Tax in
chronically HTLV-1 infected monkeys and relation to the
proviral load
The frequency of circulating effector T-cells against Tax
was evaluated by measuring IFN-γ induction by Elispot infresh PBMCs obtained from the four chronically HTLV-1-
infected monkeys. We used 32 overlapping peptides covering
the entire Tax protein (Parker et al., 1992), collected in 11
pools (each pool containing three overlapping peptides of 9–
10 amino acids) (Table 2). As seen in Fig. 6, stimulation of
PBMCs with Tax antigen induced a higher frequency of IFN-
γ-secreting cells in two HTLV-1 infected monkeys (1715 and
1491) than in the other ones (1540 and 94119). None of the 11
pools induced a significant response in two uninfected control
animals (data not shown). As shown in Table 1, monkeys
1715 and 1491, which had higher frequencies of circulating
effector T cells, also had the highest proviral loads.
Discussion
In all newly infected animals, an increased level of IFN-γ
expression was observed during primary HTLV-1 infection,
concomitantly with an increase of the numbers of CD4+, CD8+
and CD16+ cells. The expression of this cytokine at an early
stage of HTLV-1 infection is probably the result of T cell
expansion as a mechanism to control the infection and viral
spread. Interferons are well known for their antiviral properties,
their regulation of cell growth and their immunomodulatory
Fig. 4. Expression of IFN-γ, IL-2 and IL-10 cytokines and viral tax/rex mRNA as detected by RT-PCR from day 0 to day 14 in HTLV-1-infected squirrel monkeys.
Animals (A029C, A050C, A115C and 96070) were infected with an HTLV-1-transformed cell line, while the control animal (A118C) was inoculated with the same
number of Jurkat cells. To compare cytokine expression in different samples, the ratio cytokine/GAPDH was calculated by measuring the density of each
corresponding band. Values represent the mean cytokine expression of four animals. Errors bars correspond to S.E.M. among four animals.
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important regulator of innate and adaptive immune responses
and is produced only by certain cells of the immune system,
including NK cells, CD4+ T helper 1 (Th1) cells and CD8+
cytotoxic T cells. IFN-γ expression is commonly observed
during early infection, but prevailing dogma considers that this
expression has a suppressive effect on T-cell responses (DaltonFig. 5. RT-PCR pattern of Th1 and Th2 cytokine expression, including IL-2, IL-5, IL
HTLV-1-infected monkeys (animals 1491, 1540, 1715, 94119) or from uninfected
plasmid containing specific primers for each cytokine; the negative control was theet al., 2000; Refaeli et al., 2002). Nevertheless, recent works
from Whitmire et al. (2005a, 2005b) have challenged this
model. Indeed it was found that IFN-γ acts directly to increase
the number both of CD4+ and CD8+ T-cells during acute viral
infection (Whitmire et al., 2005a, 2005b). Based on our data,
our hypothesis is that early expression of IFN-γ by NK and T-
cells could facilitate T-cell expansion. The subsequent-6, IL-10 and IFN-γ, in fresh PBMCs (without culture) isolated from chronically
control animals (26C, 47C, 51C, 78C). The positive control was a competitive
plasmid alone.
Table 2
Pools containing the overlapping peptides covering the entire Tax protein and
used for in vitro stimulation of PBMCs from HTLV-I infected monkeys
Sequences of peptides used for in vitro stimulation
Pool 1
Tax 11–25 LLFGYPVYVFGDCVQ
Tax 21–35 GDCVQGDWCPISGGL
Tax 31–45 ISGGLCSARLHRHAL
Pool 2
Tax 61–75 GRVIGSALQFLIPRL
Tax 71–85 LIPRLPSFPTQRTSK
Tax 81–95 QRTSKTLKVLTPPIT
Pool 3
Tax 91–105 TPPITHTTPNIPPSF
Tax 101–115 IPPSFLQAMRKYSPF
Tax 111–125 KYSPFRNGYMEPTLG
Pool 4
Tax 121–135 EPTLGQHLPTLSFPD
Tax 131–145 LSFPDPGLRPQNLYT
Tax 141–155 QNLYTLWGGSVVCMY
Pool 5
Tax 151–165 VVCMYLYQLSPPITW
Tax 161–175 PPITWPLLPHVIFCH
Tax 171–185 VIFCHPGQLGAFLTN
Pool 6
Tax 181–195 AFLTNVPYKRIEKLL
Tax 191–205 IEKLLYKISLTTGAL
Tax 211–225 DCLPTTLFQPVRAPV
Pool 7
Tax 221–235 VRAPVTLTAWQNGLL
Tax 241–255 LTTPGLIWTFTDGTP
Tax 251–265 TDGTPMISGPCPKDG
Pool 8
Tax 261–275 CPKDGQPSLVLQSSS
Tax 265–279 GQPSLVLQSSSFIFH
Tax 271–285 LQSSSFIFHKFQTKA
Pool 9
Tax 281–295 FQTKAYHPSFLLSHG
Tax 291–305 LLSHGLIQYSSFHNL
Tax 301–315 SFHNLHLLFEEYTNI
Pool 10
Tax 311–325 EYTNIPISLLFNEKE
Tax 315–329 IPISLLFNEKEADDN
Tax 321–335 FNEKEADDNDHEPQI
Pool 11
Tax 331–345 HEPQISPGGLEPPSE
Tax 339–353 GLEPPSEKHFRETEV
Pool 12
Irrelevant peptide a GILGFVFTL
a Peptide located on the matrix protein of Influenza A virus.
Table 1
Expression of IFN-γ, determined by quantitative RT-PCR, and HTLV-1 proviral
load in PMBCs from monkeys chronically infected with HTLV-1
Monkey # Ratio IFN-γ/G3PDH (×102) Proviral load
% of PBMCs a
Total PBMCs CD4+ cells CD8+ cells
1491 100 460 20 6.6
1540 50 22 60 0.9
1715 50 30 30 4.2
94119 5 30 <1 0.15
A26Cb <1 <1 <1 Undetectable
a Percentage of HTLV-1 infected cells in the PBMCs.
b Control, uninfected monkey.
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apoptosis and to the suppression of the immune response. This
immunosuppressive effect of IFN-γ could therefore explain the
expansion of infected cells over time and the occurrence of the
disease. In our non-human primate model, we could not show
which cellular subtype is responsible for IFN-γ production
during primary HTLV-I infection. It is also possible that during
early infection, infected cells expressed IFN-γ. Further experi-
ments are needed to address this question.
Besides IFN-γ, IL-2 and IL-10 were also expressed
transiently during the first week of infection. IL-2 is the major
autocrine growth factor for T lymphocytes, and the quantity of
IL-2 synthesized by activated CD4 cells is an important
determinant of the magnitude of the T cell-dependent immune
response (Horvat et al., 1991; Swain, 1991). IL-2 also
stimulates the synthesis of other T cell-derived cytokines,
such as IFN-γ. Similar to our observation in the squirrel
monkey model, a high rate of expression of IL-2 has been
reported during primary infection of macaques with SIV
(Benveniste et al., 1996). IL-10, a regulatory cytokine is also
essential for initiation of the humoral immune response and for
activation of antigen-presenting cells. Treg cells (CD4+ CD25+)
control the immune balance by secreting IL-10 (Vieira et al.,
2004). The lack of antibodies that cross-react with CD4+ CD25+
from Saimiri monkeys obviates such an investigation.
In the present study we have also shown that tax/rex mRNA
could be detected only shortly after infection but not thereafter.
These results confirm our previous data on the tax expression
during primary infection (Kazanji et al., 2000). We have
previously demonstrated that tax/rex expression could be
detected in the PBMCs, spleen and lymph nodes 6 days post
infections of infected monkeys but was undetectable after 12–
14 days. We have also shown that the expression of tax/rex
mRNA during primary infection is not due to the inoculated
cells but results from newly infected cells in the animals
(Kazanji et al., 2000).
The profile of cytokine expression during latency indicates
that two cytokines, IL-6 and IFN-γ are up-regulated in the
PBMCs of chronically HTLV-1-infected monkeys and not in
uninfected monkeys. IL-6 up-regulation appears to be related to
the proviral load. IL-6 could play a role in the expansion of
infected cells (i.e. proviral load) due to its anti-apoptotic effect
on CD4+ cells (Ayroldi et al., 1998) and could reflect an
inflammatory state. We showed previously that three monkeys(1491, 1715 and 1540) had expansion of HTLV-1-infected Tcell
clones (Debacq et al., 2005; Mortreux et al., 2001), consistent
with the results of a recent study showing higher levels of IFN-γ
in the sera of ATLL or HAM/TSP patients and asymptomatic
Fig. 6. IFN-γ expression in four chronically infected monkeys determined by the ELISPOT assay. Isolated fresh PBMCs from chronically infected monkeys were
activated with 11 peptides pools as shown in Table 2 (each pool contains three overlapping Tax peptides). Pool 12 contained the irrelevant peptide. The numbers of
spot-forming cells were calculated after subtraction of background spots from wells containing cells and medium only, with no peptide.
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al., 2004). Inagaki et al. (2006) also found a significantly higher
level of IL-6 in ATLL patients but not in asymptomatic carriers.
The difference from our data might be due to our model or linked
to the proviral load, as Inagaki's study did not consider this
variable. IFN-γ expression appeared to be associated with
HTLV-1 infection, and our data suggest that IFN-γ is produced
by monkey Th1 cells or NK cells as an immune response to
HTLV-1-infected cells in the host. We previously demonstrated
that animals 1491 and 94119 showed a CD4+ lymphocytosis,
with the presence of flower cells and the evidence of an
expansion of a limited number of clones (n<10) (Debacq et al.,
2005; Heraud et al., 2006). These features are similar to that
observed in HTLV-1 infected human individuals suffering of
chronic or smouldering ATL. The two animals with a chronic
ATL are those in which the main IFN-γ-expressing cells were
CD4+ T-cells. IFN-γ trans-activation in HTLV-1-infected cells
(Tax-dependent or -independent) might explain this phenome-
non. In our model, it is still unclear whether the T cells that
produce IFN-γ and/or IL-6 are infected cells or simply activated
cells. Other studies are needed to explore this question. We did
not observe significant expression of IL-2 during latency,
consistent with the results of Inagaki et al. and Hanon et al. in
vivo and in vitro (Hanon et al., 2001; Inagaki et al., 2006).
In a previous study, we showed the presence of a cytolytic T-
cell response against Tax in enriched CD8+ T cells from HTLV-
1-infected squirrel monkeys. This response was detected
2 months after infection and remained detectable thereafter
(Kazanji et al., 2000). We confirm these results in our new study
by demonstrating that overlapping Tax peptides are able tostimulate the production of IFN-γ in fresh PBMCs from
chronically infected monkeys. We also showed in our non-
human primate model that the frequency of T cells secreting
IFN-γ might be associated with the proviral load and with
pathogenicity. We could not investigate which cells are involved
in this mechanism; however, Kubota et al. (2000) found a
positive correlation between a high HTLV-1 proviral load
and an increased level of HTLV-1-specific CD8+ lymphocytes
in HTLV-1-infected individuals, particularly in HAM/TSP
patients.
In conclusion, examination of cytokine expression during
primary and chronic infection with HTLV-1 infection provides
information about the dynamics of the immune response in our
non-human primate model. Th1/Th2 regulatory cells, by
expressing cytokines, play a critical role in controlling the
immune balance that prevents severe diseases like ATLL. Our
model of experimental infection is suitable for studying the
relation between host and virus, and further studies are needed to
determine whether the different patterns of cytokine and che-
mokine response during primary HTLV-1 infection are associ-
ated with the long latency by controlling HTLV-1 replication
over time. Such studies would provide important information for
the development of immune-based therapeutic strategies.
Materials and methods
Animals and HTLV-1 inoculation
Twelve 6-year-old male squirrel monkeys from the primate-
breeding centre of the Pasteur Institute of French Guiana were
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monkey HTLV-1-transformed cells, as described previously
(Kazanji et al., 1997b). They were bled at various times after
inoculation, and antibodies against HTLV-1 were measured by
enzyme-linked immunosorbent assay (ELISA; Diagnostic
Biotechnology Ltd, Singapore). HTLV-1 infection was con-
firmed by western blotting (HTLV blot 2.3, Diagnostic
Biotechnology Ltd, Singapore).
Cloning, expression and generation of anti-squirrel monkey
CD8+ polyclonal antibodies
We have shown previously that mouse anti-human CD4
monoclonal antibodies recognize CD4+ cells from squirrel
monkeys, whereas mouse anti-human CD8 monoclonal anti-
bodies do not (Kazanji, 2000). In an attempt to develop this anti-
CD8 antibody, we cloned and sequenced squirrel monkey CD8
cDNA (Ureta-Vidal et al., 1999). 293T cells were transfected
with the recombinant plasmid using the PolyFect® reagent
(QIAGEN GmbH, Hilden, Germany) according to the manu-
facturer's instructions. The identity of CD8-α protein was
studied by western blotting with an anti-His monoclonal
antibody and an anti-β-tubulin antibody as controls, as
described previously by Meertens et al. (2004). As a control,
293T cells were either mock-transfected or transfected with
pcDNA4-LacZ control plasmid (Invitrogen Corporation, Carls-
bad, CA, USA) (Fig. 1). To generate a mouse anti-squirrel
monkey CD8 antibody, 4-week-old Balb/c mice (IFFA-
CREDO, L'Arbesle, France) were given an intramuscular
injection into the tibia anterior muscle of 50 μl of phosphate-
buffered saline containing 400 μg of the naked DNA expression
vector pcDNA3.1-His/CD8α,as previously described (Kazanji
et al., 1997a). The mice were bled at various times after
immunization, and sera were collected and screened by ELISA,
as described previously (Kazanji et al., 2006), with a synthetic
peptide (PTFLLYISQTKPKVA) located on the complementary
determining region 2 (CDR2, aa 46–60) of the squirrel monkey
CD8α chain (Ureta-Vidal et al., 1999). The specificity of the
polyclonal antibody was also evaluated by flow cytometric
analysis, as described previously (Kazanji et al., 2006). As
shown in Fig. 1B, 49% of total PBMCs were CD8+ cells (B1),
and 76% of CD2+ cells from CD4+-depleted cells fraction were
CD8+ cells (B2).
Enzyme-linked immunospot (ELISPOT) assay for IFN-γ
detection
The ELISPOT assay was carried out as described previously
(Kazanji et al., 2006). Briefly, multiscreen filtration plates
(MAIPS4510, Millipore, Bedford, MA, USA) were coated with
15 μg/ml anti-IFN-γ mAb (1-D1K, Mabtech, Sweden)
overnight at 4 °C. The plates were then washed five times
with RPMI-1640 medium and blocked with RPMI 1640
supplemented with L-glu, pen/strep and 10% fetal calf serum
for 2 h. Then, 2×105 PBMCs in the above medium were added
in a total volume of 200 μl in the presence or absence of 10 μg/
ml of relevant peptide and incubated for 40 h at 37 °C. The cellswere then incubated with 100 μl of 1 μg/ml biotinylated anti-
IFN-γ mAb 7-B6-1 (Mabtech, Sweden) for 3 h at room
temperature. After washing, the substrate BCIP/NBT (Kirke-
gaard and Perry Labs, Gaithersburg, MD, USA) was added, and
the solution was incubated in the dark for 10–20 min until the
appearance of dark-blue spots. The reaction was stopped by
washing with cold tap-water, and the spots were counted
with an Immunospot Image Analyzer (Zeiss, Oberkochen,
Germany).
Cell isolation and flow cytometry analysis
PBMCs were separated from blood containing EDTA by
sucrose density centrifugation with a Ficoll-Paque gradient
(Sigma-Aldrich Co., St Louis, MO, USA) and were then washed
three times with PBS. ACD4+ Tcell isolation kit and anti-mouse
T cell lymphocyte kit microbeads (Miltenyi Biotec Ltd, Surrey,
England) were used according to the manufacturer's recom-
mendations to enrich or deplete the respective subpopulations.
Lymphocyte subsets were determined by flow cytometric
analysis with a FACScan (Becton Dickinson, Mountain View,
CA, USA). Cells were washed with PBS containing 7% normal
goat serum (Sigma-Aldrich Co., St Louis, MO, USA) and then
incubated for 30 min at room temperature with various
combinations of fluorescence (FITC)-conjugated monoclonal
antibodies (all from Becton Dickinson). The stains used
throughout the study were CD2-PE (RPA-2.10), CD4-FITC
(Leu 3a) and CD16-FITC (3G8) monoclonal antibodies. For
CD8 phenotyping assay, a polyclonal CD8 antibody produced in
our laboratory associated with a secondary anti-mouse IgG FITC
conjugate (Becton Dickinson) was used. Cells were run ungated.
For analysis, lymphocyte gates were set with CellQuest™
software (Becton Dickinson). Lymphocyte subpopulations were
calculated from the total white cell values obtained from a
complete blood count performed with PENTRA 60 C+ (ABX
Diagnostics, Montpellier, France).
Reverse transcription polymerase chain reaction (RT-PCR)
and quantification of cytokine gene expression
In order to evaluate the expression of the different cytokines
involved in the immune response to HTLV-1 infection, we used
a previously described method (Heraud et al., 2002) based on
competitive PCR and a competing plasmid, which has a
cytokine sequence containing a GAPDH sequence. The
cytokine and GAPDH primer-binding sites are identical to
those on the sample cDNA, thus competing for amplification,
although the intervening sequence is either longer or shorter.
Co-amplification of competitor and sample cDNAs with one set
of primers results in products of different sizes. Competitive
PCR was performed in a GeneAmp® PCR System 9700
thermocycler (PE Biosystems, Foster, CA, USA) for 35 cycles,
as previously described (Heraud et al., 2002). After amplifica-
tion, the products of each reaction were separated on 2% TAE
agarose gel, stained with ethidium bromide and photographed
under 300 nm ultra-violet trans-illumination (Bioblock Scien-
tific) with a CCD video camera module (BIO-PRINT® system
410 J.-M. Heraud et al. / Virology 361 (2007) 402–411from Vilber Lourmat, Torcy, France). The digitalized image was
analysed with BIO-1D software (Vilber Lourmat, Torcy,
France). The fluorescence density of the target and competitor
bands was calculated from the volume representing the sum of
all the intensities of pixels making up the whole band. The
results are expressed as cytokine:GAPDH mRNA ratio, as
previously described (Pinelli et al., 1999; Rottman et al., 1996).
Detection of HTLV-1 proviral load
Genomic DNA was extracted from PBMCs by the method
described by Ibrahim et al. (1994). The HTLV-1 proviral load
was measured as previously described (Mortreux et al., 2001)
by an accurate, reproducible, quantitative PCR method
involving a dual-labelled fluorogenic probe (ABI PRISM
7700 Sequence detection system). The lower limit of detection
is 10 copies per 1.5×105 PBMCs.
RT-PCR detection of tax/rex mRNA
Total cellular RNA was extracted from PBMCs and tissues
with TRIzol reagent (Invitrogen, Frederick, MD, USA). The
RNA was suspended in water and diluted to a final
concentration of 0.1 μg/μl. It was then mixed with 15 pmol of
the random hexamer primers in a final volume of 12.7 μl. RT
and cDNA synthesis were performed as previously described
(Kazanji et al., 2000). Immediately after cDNA synthesis, a
semi-nested PCR was carried out on the pX region, with RPX3
and RPX5 as the outer primers and RPX3 and RPX4 as the
inner primers (Kinoshita et al., 1989). To confirm the presence
of amplifiable cDNA in the samples, the primers GAPD5ScF
(sense) and GAPD3ScR (antisense) were used as described
previously (Heraud et al., 2002).
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